Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Direct head-to-head data against tirzepatide showed CagriSema underperforming the highest tirzepatide dose at 84 weeks meaning monotherapy claims of comparable efficacy are not supported by current Phase 3 evidence
Moreover, it is used off-label for chronic weight management in patients with obesity and overweight
The medication works by mimicking the action of a hormone called GLP-1, which helps regulate blood sugar and appetite
Research published in major medical journals documents these adaptations persisting for years
Obesity is recognised as a significant risk factor for fertility problems in both men and women, affecting hormone production, ovulation, sperm quality, and overall reproductive function
Key Benefits of Retatrutide 6mg Significant Body Weight Reduction: Clinical data suggests up to 24% mean body weight loss over 48 weeks, outperforming existing GLP-1 therapies
